RU2002104397A -
THERAPY FOR THE TREATMENT OF ARTHROSIS
- Google Patents
THERAPY FOR THE TREATMENT OF ARTHROSIS
Info
Publication number
RU2002104397A
RU2002104397ARU2002104397/15ARU2002104397ARU2002104397ARU 2002104397 ARU2002104397 ARU 2002104397ARU 2002104397/15 ARU2002104397/15 ARU 2002104397/15ARU 2002104397 ARU2002104397 ARU 2002104397ARU 2002104397 ARU2002104397 ARU 2002104397A
Акционерное Курганское общество медицинских препаратов и изделий "Синтез"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное Курганское общество медицинских препаратов и изделий "Синтез"filedCriticalАкционерное Курганское общество медицинских препаратов и изделий "Синтез"
Priority to RU2002104397ApriorityCriticalpatent/RU2216332C1/en
Application grantedgrantedCritical
Publication of RU2216332C1publicationCriticalpatent/RU2216332C1/en
Publication of RU2002104397ApublicationCriticalpatent/RU2002104397A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Claims (1)
Лекарственный препарат для лечения артроза, выполненный в форме капсулы и содержащий хондроитинсульфат, отличающийся тем, что он дополнительно содержит стеариновую кислоту или стеарат кальция и молочный сахар, при этом компоненты взяты в следующем соотношении в мас.ч.:A drug for the treatment of arthrosis, made in the form of a capsule and containing chondroitin sulfate, characterized in that it additionally contains stearic acid or calcium stearate and milk sugar, while the components are taken in the following ratio in parts by weight:Хондроитинсульфат 88,2-107,8 Предпочтительно 98,0Chondroitin Sulfate 88.2-107.8 Preferably 98.0Стеариновая кислотаStearic acidили стеарат кальция 0,2-1,0 Предпочтительно 1,0or calcium stearate 0.2-1.0, preferably 1.0Молочный сахар 0,2-1,0 Предпочтительно 1,0Milk sugar 0.2-1.0 Preferably 1.0
RU2002104397A2002-02-182002-02-18Curative preparation for treatment of arthrosis
RU2216332C1
(en)
Use of human IL-1beta binding antibodies and pharmaceutical compositions containing them, for the manufacture of a medicament for the treatment of juvenile rheumatoid arthritis
Heparin-Binding Protein Having Heparan Sulfate Sugar Chain Attached Thereto Process For Producing The Same And Medicinal Composition Containing The Same
Use of fenofibrate or pharmaceutically acceptable salt thereof, orlistat and pharmaceutically acceptable carrier in the manufacture of medicaments for the treatment of obesity and pharmaceutical compositions containing them
Polypeptides capable of inducing antibodies in vivo themselves capable of inhibiting the invasion of red blood cells by merozoites of P. falciparum, related products and their use in the production of vaccine compositions.